Abstract
Administration of 2-isopropyl-4-pentenamide (AIA) and 2,2-diethyl-4-pentenamide (novonal) to phenobarbital-pretreated rats gives rise to abnormal porphyrins derived from the prosthetic heme group of inactivated cytochrome P-450. The abnormal porphyrins, identified by NMR and other spectroscopic methods, are N-alkylated protoporphyrin IX derivatives in which the N-alkyl moiety is derived from the parent drug by addition of a hydroxyl group to the internal carbon and of a porphyrin nitrogen to the terminal carbon of the pi-bond. A secondary reaction of the hydroxyl with the amide group converts the N-alkyl moiety into a lactone. The indicated alkylation-lactonization sequence is supported by the fact that the AIA adduct formed under an atmosphere of 18O2 incorporates one labeled oxygen atom. The regiochemistry of heme alkylation is consistent with a previously postulated active site topology [J. Biol. Chem. 258:4202-4207 (1983)].
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|